Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.

× No keyword cloud information.

10 in total

1. Pro-permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; The Ozurdex for Retinal Vein Occlusion (ORVO) Study.

Authors: Dan Călugăru; Mihai Călugăru
Journal: Am J Ophthalmol Date: 2015-10-23 Impact factor: 5.258

2. Re: Yeh et al.: Ophthalmic Technology Assessment: therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology (Ophthalmology 2015;122:769-78).

Authors: Dan Călugăru; Mihai Călugăru
Journal: Ophthalmology Date: 2015-11 Impact factor: 12.079

3. Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion.

Authors: Gabriel Coscas; Albert Augustin; Francesco Bandello; Marc D de Smet; Paolo Lanzetta; Giovanni Staurenghi; Maria Cristina Parravano; Patricia Udaondo; Elad Moisseiev; Gisele Soubrane; Yossi Yatziv; Anat Loewenstein
Journal: Eur J Ophthalmol Date: 2013-10-14 Impact factor: 2.597

Review 4. TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations.

Authors: K Bailey Freund; Jean-François Korobelnik; Robert Devenyi; Carsten Framme; John Galic; Edward Herbert; Hans Hoerauf; Paolo Lanzetta; Stephan Michels; Paul Mitchell; Jordi Monés; Carl Regillo; Ramin Tadayoni; James Talks; Sebastian Wolf
Journal: Retina Date: 2015-08 Impact factor: 4.256

5. Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study.

Authors: Dan Călugăru; Mihai Călugăru
Journal: Acta Ophthalmol Date: 2015-07-06 Impact factor: 3.761

6. Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study.

Authors: Dan Călugăru; Mihai Călugăru
Journal: J Ocul Pharmacol Ther Date: 2014-10-14 Impact factor: 2.671

7. Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).

Authors: Sandeep Grover; Ravi K Murthy; Vikram S Brar; Kakarla V Chalam
Journal: Am J Ophthalmol Date: 2009-05-09 Impact factor: 5.258

8. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography.

Authors: Annie Chan; Jay S Duker; Tony H Ko; James G Fujimoto; Joel S Schuman
Journal: Arch Ophthalmol Date: 2006-02

9. Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion.

Authors: Baruch D Kuppermann; Julia A Haller; Francesco Bandello; Anat Loewenstein; Jenny Jiao; Xiao-Yan Li; Scott M Whitcup
Journal: Retina Date: 2014-09 Impact factor: 4.256

10. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.

Authors: Jean-François Korobelnik; Laurent Kodjikian; Cécile Delcourt; Vincent Gualino; Richard Leaback; Sybil Pinchinat; Marie-Eve Velard
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2016-06-11 Impact factor: 3.117

10 in total

1 in total

1. Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study.

Authors: Dan Călugăru; Mihai Călugăru
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-02-04 Impact factor: 3.117

1 in total